AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 19 filers reported holding AMBRX BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 3.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,122,424 | -27.9% | 9,923,689 | +3.2% | 6.66% | -24.9% |
| Q2 2023 | $158,281,911 | +208660.1% | 9,616,155 | +13.1% | 8.87% | +77.6% |
| Q1 2023 | $75,820 | +1329.5% | 8,500,000 | +263.8% | 4.99% | +1306.5% |
| Q4 2022 | $5,304 | -99.8% | 2,336,389 | 0.0% | 0.36% | +101.7% |
| Q3 2022 | $2,523,000 | -61.7% | 2,336,389 | -6.0% | 0.18% | -64.7% |
| Q2 2022 | $6,589,000 | -35.7% | 2,486,386 | 0.0% | 0.50% | -36.7% |
| Q1 2022 | $10,244,000 | -54.4% | 2,486,386 | 0.0% | 0.79% | -41.0% |
| Q4 2021 | $22,452,000 | -32.2% | 2,486,386 | 0.0% | 1.34% | -0.7% |
| Q3 2021 | $33,097,000 | -29.6% | 2,486,386 | 0.0% | 1.34% | -15.8% |
| Q2 2021 | $47,032,000 | – | 2,486,386 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 11,304,573 | $100,836,791 | 27.58% |
| COMMODORE CAPITAL LP | 4,803,447 | $42,846,747 | 6.52% |
| VR Adviser, LLC | 3,298,577 | $29,423,307 | 5.74% |
| Cormorant Asset Management, LP | 8,500,000 | $75,820 | 4.99% |
| Ghost Tree Capital, LLC | 250,000 | $2,230,000 | 0.66% |
| TOMS Capital Investment Management LP | 1,000,000 | $8,920,000 | 0.55% |
| Artal Group S.A. | 702,291 | $6,264 | 0.37% |
| Fosun International Ltd | 249,190 | $2,222,775 | 0.21% |
| D. E. Shaw & Co., Inc. | 3,933,552 | $35,087,284 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 361,000 | $3,220,120 | 0.02% |